---
title: "17:00 ETDaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293386158.md"
description: "DaVita Inc. (NYSE: DVA) announced it will hold its Second Quarter 2026 investor conference call on Tuesday, August 4, 2026, at 5:00 p.m. Eastern Time to discuss quarterly results. The company plans to release these results after market close on the same day. The call will be webcast and accessible via DaVita's IR webpage, with dial-in options available for investors."
datetime: "2026-07-21T21:00:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293386158.md)
  - [en](https://longbridge.com/en/news/293386158.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293386158.md)
---

# 17:00 ETDaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

, /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 4, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

Tuesday, August 4, 2026  
Starting at 5:00 p.m. EDT  
Webcast can be accessed using this link  
Dial in number: 877-918-6630  
International dial in: 517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

**About DaVita Inc.**

DaVita (NYSE: DVA) is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey — from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of March 31, 2026, DaVita served approximately 296,300 patients at 3,262 outpatient dialysis centers, of which 2,666 centers were located in the United States and 596 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

**Contact Information**  
Investors:  
\[email protected\]

SOURCE DaVita

### Related Stocks

- [DVA.US](https://longbridge.com/en/quote/DVA.US.md)

## Related News & Research

- [Dialysis provider DaVita's Q2 results beat estimates, aided by higher average rates](https://longbridge.com/en/news/294866361.md)
- [DaVita Inc. $DVA Shares Sold by Empowered Funds LLC](https://longbridge.com/en/news/295626043.md)
- [14:37 ET/C O R R E C T I O N -- Heartbeat Health/](https://longbridge.com/en/news/295568392.md)
- [CitroTech Provides Q2 2026 Business Update in Letter to Shareholders](https://longbridge.com/en/news/295561956.md)
- [13:31 ETChapters Health System Announces Expansion of Care in Sarasota County](https://longbridge.com/en/news/295564893.md)